Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Companion diagnostic tests
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
See all tags

MTRC has released a White Paper "Case study: Market Access Pathway for Preeclampsia Predictive Tests in Germany and Norway"

Diverse healthcare structures and reimbursement pathways in Europe present unique challenges for in-vitro diagnostic (IVD) tests companies. Varying reimbursement frameworks, technology assessment processes, and funding mechanisms can complicate the rollout of new diagnostic tests. This White Paper provides a detailed case study on how developers of IVD tests can effectively navigate reimbursement pathways in key European markets using the examples of pathways in Germany and Norway.

Key highlights of this case study include:

  • General overview of the market access environment for IVDs in Germany and Norway
  • Integration of laboratory test coding within the EBM catalog in Germany and the NLK system in Norway
  • Reimbursement milestones for PlGF and sFlt-1/PlGF ratio tests, including recent tariff changes
  • Role of the Evaluation Committee and G-BA in Germany and the impact of national HTA evaluations on access and funding decisions
  • Example of local-level test adoption despite negative national coverage decisions in Norway

Read more and request a White Paper here.

Tags
Services of MTRC

The latest related news

05
May 2025

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 5th of May, we plan to work on 19 projects. Review the complete list of planned activities in this post.
Read more